StockStory.org on MSN2d
Masimo (MASI): Buy, Sell, or Hold Post Q4 Earnings?What a fantastic six months it’s been for Masimo. Shares of the company have skyrocketed 45.8%, hitting $167.70. This was ...
Baraa Kahf is a litigation partner and diversity committee chair at Knobbe Martens, specializing in intellectual property law ...
Zynex develops, manufactures, markets and sells medical devices used for nerve stimulation, pain management, and rehabilitation, as well as non-invasive fluid, sepsis, and laser-based pulse oximetry ...
M&T Bank Corp grew its position in shares of Masimo Co. (NASDAQ:MASI – Free Report) by 4.9% in the 4th quarter, ...
The Alabama Midwives Alliance (ALMA) is advocating for the passage of a bill that would clarify and allow licensed midwives ...
Zynex specializes in non-invasive pain management and patient monitoring, with promising advancements. Read why I think ZYXI ...
The draft guidance addresses criticisms that pulse oximeters are less accurate for people with dark skin tones. Experts ...
Apple Watch Series 10 is Apple's latest and greatest smartwatch. Here, we'll discuss all the reasons you should get one right ...
Masimo SET ® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results